Q-Line Biotech Limited Q

About

The journey started in name of POCT Services Pvt Ltd, (at present; Q-Line Biotech Pvt. Ltd.) with around 20 employees and imported products from France, USA, Spain, South Korea and Sweden. 2014-2015In the year 2013, when Merck Diagnostics India has decided to discontinue itsIVD operations in India, few brainchild of diagnostics professionalshas decided to continue its IVD business operation by takingthe established IVD products of Merck. The journey started in name of POCT Services Pvt Ltd, (at present; Q-Line Biotech Pvt. Ltd.) with around 20 employees and imported products from France, USA, Spain, South Korea and Sweden.2016Entering into product development and establishment of 1stISO13485:16production units at capital of India; Delhi. Successfully received NOD from CDSCO and state FDA for production and commercialization of 20 + Biochemistry parameters.2017Technology transfer for indigenous manufacturing of electrolyte reagents and expansion of product basket by introducing electrolyte analyzer, coagulation and electrophoresis.2018- 2019Joined hand and JVC agreement with a South Korean company for POC product range as well as Rt-PCR and molecular assays and expanded the manufacturing unit for the manufacturing of glucometer and glucose strips, Hb meter and strips, lipid meter and its strips.Investment on R &D for Instrument and reagent development. Set-up of 2nd unit GMP certified manufacturing unit for rapid range of products (Lateral Flow Assay) and ELISA kits(hCG, HIV, HBsAg, HCV, Syphilis, Malaria, Dengue).2020Company signed MOU with RGCB, Department of Biotechnology- Govt of India and similar institutions for technical support in product development and quality evaluation. Company glad to get NOD from CDSCO, ICMR, Indian-FDA , CE of Indigenous Rt-PCR kits, Nucleic Acid Extraction kits, ELISA kit and Rapid Cards, Viral transport Medium. Contract awarded to run 137 district hospital laboratories.2021Change of Organisation name to Q-Line Biotech Private Limited